- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04842500
Translational Research to Inform Interventions for Challenging Behavior
Translational Research to Inform Interventions for Severe Challenging Behavior for Individuals With Intellectual and Developmental Disabilities
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Gallatin, Tennessee, United States, 37066
- Habilitative and Training Services (HATS)
-
Lebanon, Tennessee, United States, 37060
- Easterseals Tennessee: Prospect
-
Murfreesboro, Tennessee, United States, 37133
- Possibility Place
-
Nashville, Tennessee, United States, 37203
- Next Steps at Vanderbilt
-
-
Utah
-
Orem, Utah, United States, 84057
- Chrysalis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be older than 18.
- Participants must have a developmental disability (unconstrained to specific diagnoses).
- Participants must be able to correctly manipulate all items used in the study.
- Participants must consent (or assent, when relevant) to procedures prior to and throughout the study.
Exclusion Criteria:
- Participants younger than 18.
- Participants without disabilities.
- Participants who cannot correctly manipulate items used in the study.
- Participants who do not consent (or assent, when relevant) to participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: "Cheap" Unit Price, Establishing Operation
Pre-extinction baseline unit price for the programmed reinforcer will be its Pmax, minus one half of the distance between its Pmax and its breakpoint.
Extinction will be introduced at the beginning of the relevant appointment, before within-appointment reinforcer consumption has had an opportunity to approximate demand.
|
This analysis is designed to determine the degree to which relative price, and the timing of extinction, interact to increase or abate responding during extinction (thereby highlighting mechanisms of control).
|
|
Experimental: "Cheap" Unit Price, Abolishing Operation
Pre-extinction baseline unit price for the programmed reinforcer will be its Pmax, minus one half of the distance between its Pmax and its breakpoint.
Extinction will be introduced at the end of the relevant appointment, after within-appointment reinforcer consumption has approximated demand.
|
This analysis is designed to determine the degree to which relative price, and the timing of extinction, interact to increase or abate responding during extinction (thereby highlighting mechanisms of control).
|
|
Experimental: "Expensive" Unit Price, Establishing Operation
Pre-extinction baseline unit price for the programmed reinforcer will be its Pmax, plus one half of the distance between its Pmax and its breakpoint.
Extinction will be introduced at the beginning of the relevant appointment, before within-appointment reinforcer consumption has had an opportunity to approximate demand.
|
This analysis is designed to determine the degree to which relative price, and the timing of extinction, interact to increase or abate responding during extinction (thereby highlighting mechanisms of control).
|
|
Experimental: "Expensive" Unit Price, Abolishing Operation
Pre-extinction baseline unit price for the programmed reinforcer will be its Pmax, plus one half of the distance between its Pmax and its breakpoint.
Extinction will be introduced at the end of the relevant appointment, after within-appointment reinforcer consumption has approximated demand.
|
This analysis is designed to determine the degree to which relative price, and the timing of extinction, interact to increase or abate responding during extinction (thereby highlighting mechanisms of control).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Response Rate During Extinction
Time Frame: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
This term describes the highest rate of responding observed during extinction and will be depicted as a proportion of baseline.
For example, assuming the mean rate of responding during the final three sessions of baseline is 3 responses per minute (i.e., [2.8 rpm + 3.2 rpm + 3 rpm] / 3 = 3 rpm), and the highest rate of responding during a single session of extinction is 3.4 rpm, then peak response rate for this hypothetical individual would be 1.13 (i.e., 3.4 / 3 = 1.13).
This value will serve as the primary dependent variable for each participant in all between-groups comparisons in our data-analysis plan.
|
This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
|
Schedule Value at Breakpoint
Time Frame: PRA breakpoints were obtained during pre-assessment and were used as a matching variable prior to random assignment.
|
The progressive-ratio reinforcer analysis (PRA) is a game of diminishing returns that is considered an assessment of reinforcer value (e.g., if a participant does not value the reinforcer, they will quit sooner than a participant that does value the reinforcer). During the assessment, we increased the "price" (i.e., the schedule value) of reinforcers each time a participant earns two reinforcers at a currently established price. The breakpoint describes the "price" (schedule value; e.g., FR1, FR4, FR7) of the last obtained reinforcer prior to response cessation (i.e., the breakpoint is the last schedule value that supported enough responding to produce a reinforcer, before the participant quit playing the game). Higher breakpoints are interpreted as reflecting higher-value reinforcers. Lower breakpoints are interpreted as reflecting lower-value reinforcers. |
PRA breakpoints were obtained during pre-assessment and were used as a matching variable prior to random assignment.
|
|
The Schedule Value Designated as Pmax
Time Frame: Pmax values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.
|
The progressive fixed-ratio reinforcer analysis (PFRA) is an assessment of consumer demand that first establishes how much of a reinforcer a participant would consume when consumption is free of constraint (i.e., when participants can have as much of the reinforcer as they want; referred to as "bliss-point consumption"). With bliss-point consumption established, PFRA evaluates how much a participant will "spend" (respond) to maintain bliss-point consumption patterns as price (schedule value) is increased. Unlike PRA, prices in the PFRA are held constant within each session and only increase across sessions. Initially, participants "spend" more. Eventually, they "spend" less. The price that produces maximum "spending" (i.e., higher and lower prices yield lower response outputs) is referred to as Pmax. Pmax is one way to quantify a reinforcer's value. That is, reinforcers that produce high Pmax have more value than reinforcers that produce low Pmax. |
Pmax values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.
|
|
Response Latency
Time Frame: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
This term describes the latency from session onset to eventual response cessation during the extinction challenge.
|
This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Sessions in Extinction
Time Frame: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
In addition to between-groups differences in peak-response rate (primary dependent variable), the investigators will also compare between-groups differences in the number of sessions required to achieve response elimination during extinction.
|
This measure was obtained throughout the primary assessment (i.e., the extinction challenge)
|
|
Overall Session Duration
Time Frame: Duration values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.
|
The investigators will measure the total duration of PFRA sessions (in seconds) at Pmax to establish baseline-session parameters.
|
Duration values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB #202204
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavior and Behavior Mechanisms
-
University of FloridaNational Institute of Dental and Craniofacial Research (NIDCR)RecruitingChild Behavior | Behavior and Behavior MechanismsUnited States
-
Christian RuffNot yet recruitingBehavior and Behavior Mechanisms
-
Duke UniversityTerminatedBehavior and Behavior MechanismsUnited States
-
New York UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Hôpital le VinatierTerminatedBehavior and Behavior MechanismsFrance
-
New York UniversityPlanned Parenthood Federation of AmericaCompletedBehavior and Behavior MechanismsUnited States
-
New York UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBehavior and Behavior MechanismsUnited States
-
Johns Hopkins UniversityCompletedBehavior and Behavior MechanismsUnited States
-
University of GeorgiaZeaVision, LLCCompletedBehavior and Behavior MechanismsUnited States
-
University of MichiganRobert Wood Johnson FoundationCompletedBehavior and Behavior MechanismsUnited States
Clinical Trials on Demand Informed Moderator Analysis
-
Centre Hospitalier Universitaire de NīmesCompletedPregnancy Complications | Pregnancy | Healthy VolunteersFrance
-
Centre Hospitalier Universitaire de la RéunionActive, not recruiting
-
Centre Hospitalier Universitaire de NiceCompletedMuscular DystrophiesFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPolycystic Ovary Syndrome | Familial Partial Lipodystrophy | LMNA (LaMin Nuclear A) Related DisordersFrance
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Stage I Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States